Ulinastatin is a novel candidate drug for sepsis and secondary acute lung injury, evidence from an optimized CLP rat model

Ulinastatin is a novel candidate drug for sepsis and secondary acute lung injury, evidence from an optimized CLP rat model

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Immunopharmacology - Volume 17, Issue 3, November 2013, Pages 799-807

Ning Wang, Xin Liu, Xinchuan Zheng, Hongwei Cao, Guo Wei, Yuanfeng Zhu, Shijun Fan, Hong Zhou, Jiang Zheng,